Latest News

New Developments in CAR T Treatments Webinar Series Summary
New Developments in CAR T Treatments Webinar Series Summary

December 24th 2024

The "New Developments in CAR T Treatments" webinar series brought together leading experts in the field of cancer immunotherapy to discuss the latest advancements and ongoing research in CAR T and natural killer cell therapies.

3 Things You Should Know About Hemolytic Anemias
3 Things You Should Know About Hemolytic Anemias

December 20th 2024

NX-5948 Earns Fast Track Designation in R/R Waldenström Macroglobulinemia
NX-5948 Earns Fast Track Designation in R/R Waldenström Macroglobulinemia

December 19th 2024

Results from the phase 3 AVA-PED-301 trial support the FDA decision for avatrombopag in pediatric thrombocytopenia.
FDA Accepts NDA for Avatrombopag in Pediatric Thrombocytopenia

December 17th 2024

More than 80% of the SENTRY trial population had alleviation of their myelofibrosis-associated symptoms following treatment with selinexor/ruxolitinib.
Selinexor Combo Shows Activity in Myelofibrosis Spleen Responses, Symptoms

December 13th 2024